(Q39462845)

12 September 2017

title

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors (English)

1 reference

12 September 2017

0 references

0 references

1 reference

Clostridium perfringens

object named as

Clostridium perfringens

1 reference

S Petkov

2

0 references

author name string

W Walther

1

1 reference

12 September 2017

O N Kuvardina

3

1 reference

12 September 2017

J Aumann

4

1 reference

12 September 2017

D Kobelt

5

1 reference

12 September 2017

I Fichtner

6

1 reference

12 September 2017

M Lemm

7

1 reference

12 September 2017

J Piontek

8

1 reference

12 September 2017

I E Blasig

9

1 reference

12 September 2017

U Stein

10

1 reference

12 September 2017

P M Schlag

11

1 reference

12 September 2017

publication date

6 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

19

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

494-503

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2011.136

12 September 2017

exact match

0 references

cites work

Gene therapy clinical trials worldwide to 2007--an update.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Therapeutic genes for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Bacteria and bacterial toxins as therapeutic agents for solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Cell-specific Cre-mediated activation of the diphtheria toxin gene in pituitary tumor cells: potential for cytotoxic gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Inhibition of tumor growth by DT-A expressed under the control of IGF2 P3 and P4 promoter sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Suicide cancer gene therapy using pore-forming toxin, streptolysin O.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Claudin proteins in human cancer: promising new targets for diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

The claudin gene family: expression in normal and neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Fine mapping of the N-terminal cytotoxicity region of Clostridium perfringens enterotoxin by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

A novel tumor-targeted therapy using a claudin-4-targeting molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

A claudin-targeting molecule as an inhibitor of tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Turn a diarrhoea toxin into a receptor-mediated therapy for a plethora of CLDN-4-overexpressing cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Pyroptosis: host cell death and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Novel jet-injection technology for nonviral intratumoral gene transfer in patients with melanoma and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Molecular determinants of the interaction between Clostridium perfringens enterotoxin fragments and claudin-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

7 January 2021

Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

7 January 2021

Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

7 January 2021

The molecular mode of action of Clostridium perfringens enterotoxin

1 reference

https://api.crossref.org/works/10.1038%2FGT.2011.136

7 January 2021

Identifiers

DOI

10.1038/GT.2011.136

1 reference

12 September 2017

1 reference